These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 32754263

  • 1. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D, Wang Y, Lu R, Jiang X, Chen X, Meng N, Chen M, Xie S, Yan GR.
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B.
    J Exp Clin Cancer Res; 2021 Sep 22; 40(1):299. PubMed ID: 34551796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C, Yao Y, Liu Q.
    Mol Cancer; 2014 May 17; 13():110. PubMed ID: 24884509
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X, Lei K, Liu Z, Wang Y, Li L, Bao H, Wang J, Tu K.
    Mol Cancer; 2017 Dec 20; 16(1):178. PubMed ID: 29262861
    [Abstract] [Full Text] [Related]

  • 10. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y, Tao R, Wu SS, Xu CC, Wang JL, Chen J, Yu YS, Tang ZH, Chen XH, Zang GQ.
    J Exp Clin Cancer Res; 2018 Jun 13; 37(1):116. PubMed ID: 29898761
    [Abstract] [Full Text] [Related]

  • 11. MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation.
    Cai X, Gao J, Yan Z, Zhang H, Guo D, Zhang S.
    J Cancer Res Clin Oncol; 2024 Jun 11; 150(6):303. PubMed ID: 38861187
    [Abstract] [Full Text] [Related]

  • 12. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
    Chen J, Mitra A, Li S, Song S, Nguyen BN, Chen JS, Shin JH, Gough NR, Lin P, Obias V, He AR, Yao Z, Malta TM, Noushmehr H, Latham PS, Su X, Rashid A, Mishra B, Wu RC, Mishra L.
    Cancer Res; 2020 May 01; 80(9):1819-1832. PubMed ID: 32127355
    [Abstract] [Full Text] [Related]

  • 13. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
    Li X, Yuan J, Song C, Lei Y, Xu J, Zhang G, Wang W, Song G.
    Cell Death Differ; 2021 Aug 01; 28(8):2315-2332. PubMed ID: 33649471
    [Abstract] [Full Text] [Related]

  • 14. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
    Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM.
    PLoS One; 2014 Aug 01; 9(1):e86872. PubMed ID: 24466275
    [Abstract] [Full Text] [Related]

  • 15. FAM188B promotes the growth, metastasis, and invasion of hepatocellular carcinoma by targeting the hnRNPA1/PKM2 axis.
    Mu M, Lu Y, Tu K, Tu L, Guo C, Li Z, Zhang X, Chen Y, Liu X, Xu Q, Huang D, Li X.
    Biochim Biophys Acta Mol Cell Res; 2024 Oct 01; 1871(7):119773. PubMed ID: 38844182
    [Abstract] [Full Text] [Related]

  • 16. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X.
    Oncotarget; 2015 Feb 10; 6(4):2538-48. PubMed ID: 25576919
    [Abstract] [Full Text] [Related]

  • 17. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
    Tan HW, Leung CO, Chan KK, Ho DW, Leung MS, Wong CM, Ng IO, Lo RC.
    Int J Cancer; 2019 Oct 01; 145(7):1860-1873. PubMed ID: 30834518
    [Abstract] [Full Text] [Related]

  • 18. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A, Xiang Y, Si YR, Fan LJ, Li JP, Li H, Guo W, He HX, Liang XJ, Tan Y, Bao LY, Liao XH.
    J Cell Biochem; 2019 Apr 01; 120(4):6542-6554. PubMed ID: 30368881
    [Abstract] [Full Text] [Related]

  • 19. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
    Yang W, Wang B, Yu Q, Liu T, Li T, Tian T, Jin A, Ding L, Chen W, Wang H, Xian J, Pan B, Zhou J, Fan J, Yang X, Guo W.
    Theranostics; 2022 Apr 01; 12(14):6189-6206. PubMed ID: 36168627
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y, Huang S, Qiu F, Ding X, Sun Y, Wei C, Hu X, Wei K, Long S, Xie L, Xun Y, Chen W, Zhang Z, Liu N, Xiang S.
    EBioMedicine; 2020 Jan 01; 51():102603. PubMed ID: 31901862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.